Scribner J D, Miller J A, Miller E C
Carcinogenesis. 1980 May;1(5):419-21. doi: 10.1093/carcin/1.5.419.
Ashby et al. (Carcinogenesis 1:1-7, 1980) have reported that 4-N-pyrrolidinylazobenzene is a powerful toxin and transforming agent in BHK cells. They have also proposed a scheme for the prediction of carcinogenic activity which is based on structural analysis of this and other compounds, including N-methyl-5-phenylazoindoline, tested in their BHK system. Contrary to their prediction, we found that 4-N-pyrrolidinylazobenzene and N-methyl-5-phenylazoindoline were not carcinogenic when fed to adult rats under conditions where N,N-dimethyl-4-aminoazobenzene induced a high incidence of hepatic carcinomas. 4'-Ethyl substitution of the pyrrolidine derivative yielded a weak carcinogen. These data suggest that complex structure-activity analyses for carcinogenic activity in this class of compounds are premature in the absence of data on whole animals. The transformation of BHK cells appears to require further validation as a predictor of the carcinogenic activity of chemicals for animals.
阿什比等人(《癌变》第1卷,第1 - 7页,1980年)报告称,4 - N - 吡咯烷基偶氮苯在BHK细胞中是一种强效毒素和转化剂。他们还提出了一种预测致癌活性的方案,该方案基于对在其BHK系统中测试的此化合物及其他化合物(包括N - 甲基 - 5 - 苯基偶氮吲哚)的结构分析。与他们的预测相反,我们发现,在N,N - 二甲基 - 4 - 氨基偶氮苯诱发肝癌高发的条件下,将4 - N - 吡咯烷基偶氮苯和N - 甲基 - 5 - 苯基偶氮吲哚喂给成年大鼠时,它们并无致癌性。吡咯烷衍生物的4'- 乙基取代产生了一种弱致癌物。这些数据表明,在缺乏全动物数据的情况下,对这类化合物的致癌活性进行复杂的构效分析为时过早。BHK细胞的转化作为化学物质对动物致癌活性的预测指标,似乎需要进一步验证。